DARZALEX
20MG/ML INF CNC SOL 1X5ML
| SÚKL code | 0209329 |
|---|---|
| Name of the product | DARZALEX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | DARZALEX |
| Supplement | 20MG/ML INF CNC SOL 1X5ML |
| Strenght | 20MG/ML |
| Pharmaceutical form | Concentrate for solution for infusion |
| Package | 1X5ML |
| Route | Intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | DARATUMUMAB (DARATUMUMABUM) |
| ATC group | L01FC01 |
| ATC group name | DARATUMUMAB |
| Doping | Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | EU/1/16/1101/001 |
|---|---|
| Type of MA | Orphan medicinal products |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Janssen-Cilag International N.V., Beerse |
| MA Holder country | BELGIE |
cz